Recently, on the first of July, Werner Koopman, theme Metabolic diseases, celebrated his 25th anniversary at the Radboudumc. After his training to become a biochemical engineer, he studied chemistry at the former ‘Catholic University Nijmegen’, followed by a PhD in Cellular Animal Physiology at the same university. During his PhD, he became fascinated by the biochemistry of the living cell and the possibilities to visualize this using a microscope. In the following 25 years, he has expanded this research with great effort at the department of Biochemistry at the Radboudumc.
All these years his creed had been ‘from images to numbers’: microscopy images from biochemical processes in single cells are only informative when you are able to obtain quantitative information from these images, which you can subsequently analyze statistically for large numbers of cells. An excellent description of his approach can be found in his publication in the New England Journal of Medicine (N Engl J Med 2012; 366:1132-1141): a unique approach for which he received great (inter)national recognition, leading to numerous collaborations and participation in large (European) projects.
One of the key points of his research is (dys)function of mitochondria, the powerhouses of our cells. This research has contributed to the establishment of the company Khondrion, which aims to develop therapies to combat mitochondrial diseases. Because of his specific expertise, he was recently given a part-time appointment at the Department of Human and Animal Physiology at Wageningen University and Research, which is an important contribution to the collaboration between both universities. ~ Peter Willems
Related news items
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more
Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.29 July 2020
These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.read more
Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process28 July 2020
''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.read more